[VIVO] QoQ Quarter Result on 30-Sep-2020 [#Q4]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
23-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q4]
Profit Trend
QoQ- -76.40%
YoY- 58.25%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 63,511 85,264 92,917 64,153 84,797 57,296 47,421 21.52%
PBT 15,295 33,052 34,248 7,747 34,873 12,647 4,026 143.67%
Tax 3,626 6,750 7 1,254 7,366 3,288 1,199 109.26%
NP 11,669 26,302 26,779 6,493 27,507 9,359 2,827 157.54%
Tax Rate -23.71% -20.42% -0.02% -16.19% -21.12% -26.00% -29.78% -
Total Cost 51,842 58,962 66,138 57,660 57,290 47,937 44,594 10.57%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 18.37 30.85 28.82 10.12 32.44 16.33 5.96 111.93%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS 0.27 0.61 0.62 0.15 0.64 0.22 0.07 146.15%
EPS Diluted 0.26 0.60 0.61 0.15 0.64 0.22 0.07 140.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.